These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5403803)

  • 1. [Behavior of organic sodium and blood pressure levels in uremic subjects undergoing continuous hemodilaytic treatment].
    Lamperi S; Sitia L; Bandiani G
    Minerva Nefrol; 1969; 16(6):407-12. PubMed ID: 5403803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the sodium content of the dialytic fluid in periodic hemodialysis. Data on the behavior of arterial pressure, corporeal sodium pattern and the plasma renin activity in some hypertensive, chronic uremic patients treated with dialysis with a bath with varying sodium content].
    Romagnoli GF; Huber W; Di Landro D; Bertoli M; Antonello A; Cerutti M; Chini M
    Minerva Nefrol; 1975; 22(4-5):205-11. PubMed ID: 1207978
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood pressure values and organic content of sodium in the pre- and post-dialysis phases, evaluated in uremic patients exposed to continuous dialytic treatment].
    Lamperi S; Sitia L; Bandiani G
    Minerva Nefrol; 1969; 16(1):51-4. PubMed ID: 5768267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Exchangeable sodium, water spaces, blood renin and arterial pressure in a group of chronic uremics in periodic hemodialytic therapy, undergoing binephrectomy].
    Romagnoli GF; Borsatti A; Giongo A; Muolo A; Huber W; Galvani E; Guarnieri GF; Mioni G
    G Clin Med; 1969 Dec; 50(12):1197-206. PubMed ID: 5386468
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antirenin activity of practolol in uremic subjects under hemodialysis treatment].
    Splendiani G; Giammaria U; D'Alessandro V; Marinangeli G; De Meo F
    Minerva Nefrol; 1975; 22(2-3):93-8. PubMed ID: 1226256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polycentric analysis of the behavior of uremic patients undergoing dialysis].
    Figus S; Zammit A; Bordoni E; Mioli V; Capobianco P; Martarelli D; Cecchini F; De Jasi A; Capponi E; Panichi N; Castelli F; Concetti M
    Minerva Nefrol; 1982; 29(4):215-21. PubMed ID: 7155441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Substitutive treatment of the uremic diabetic. 8 years of experience and new prospects].
    Triolo G; Thea A; Carta Q; Stratta P; Vacha GM; Giorda G; Paola M; Segoloni GP; Piccoli G; Vercellone A
    Minerva Nefrol; 1981; 28(3):315-20. PubMed ID: 7329609
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term haemodialysis treatment with sodium removal by convection.
    Locatelli F; Pedrini L; Ponti R; Costanzo R; Di Filippo S; Marai P; Pozzi C; Bonacina GP
    Proc Eur Dial Transplant Assoc; 1981; 18():146-52. PubMed ID: 7329962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].
    Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R
    Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exchangeable sodium and water spaces in chronic uremia during intermittent hemodialytic treatment].
    Romagnoli GF; Mendola R; Bruschi E; Borsatti A; Muolo A; Mioni G; Huber W
    Minerva Nefrol; 1968; 15(5):336-41. PubMed ID: 5743462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic hemodynamic studies of uremic patients with external shunts or internal fistulas].
    Zucchelli P; Garofalo FA; Lombardi G; Sasdelli M; Pinelli G; Fusaroli M
    Minerva Med; 1971 Feb; 62(17):797-810. PubMed ID: 5551767
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gynecomastia in the uremic patient undergoing periodic hemodialytic treatment].
    Sodi A; Rizzo M; Somigli M
    Minerva Nefrol; 1969; 16(6):420-4. PubMed ID: 5403806
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Target blood pressure for uremic patients on intermittent hemodialysis].
    Lusenti T
    G Ital Nefrol; 2008; 25(6):612. PubMed ID: 19048552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intracellular repercussions of alkaline therapy in chronic uremic patients].
    Acquarone N; Bertocchi I; De Ferrari G; Guerreri G; Menozzi PG; Tizianello A
    Minerva Nefrol; 1971; 18(2):102-9. PubMed ID: 5566455
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relation between asymmetrical hypertrophy of the interventricular septum and plasma levels of catecholamines in normotensive chronic uremic patients undergoing hemodialysis treatment].
    Bernardi D; Bernini L; Cini G; Nesti E; Brandinelli Geri A; Ferreri A; Urti DA; Bonechi I
    G Ital Cardiol; 1984 Dec; 14(12):999-1005. PubMed ID: 6241912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory function during chronic hemodialysis.
    Bower JD; Coleman TG
    Trans Am Soc Artif Intern Organs; 1969; 15():373-7. PubMed ID: 5791412
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.